ToddDTillmannsMD
Oncology • Germantown, TNGynecologic Cancer
Professor, Division Chief and Program Director of Gynecologic Oncology University of Tennessee Health Science Center College of Medicine and West Cancer Center Research Institute
Dr. Tillmanns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7945 Wolf River Blvd
Germantown, TN 38138Phone+1 901-683-0055Fax+1 901-922-6701
Education & Training
University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 2000 - 2003
Medical College of Wisconsin Affiliated HospitalsResidency, Obstetrics and Gynecology, 1996 - 2000
Creighton University School of MedicineClass of 1996- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology
Certifications & Licensure
AR State Medical License 2012 - 2025
MS State Medical License 2003 - 2025
TN State Medical License 2003 - 2025
OK State Medical License 2000 - 2004
WI State Medical License 1997 - 2001
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2009-2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Laparoscopic Approach to Cervical Cancer Start of enrollment: 2008 Jan 01
- Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors Start of enrollment: 2009 Apr 01
- Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAdvanced endometrial cancer-The next generation of treatment: A society of gynecologic oncology journal club clinical commentary.Todd Tillmanns, Amal Masri, Chelsea Stewart, Dana Chase, Anthony Karnezis
Gynecologic Oncology Reports. 2024-10-01 - 70 citationsDurvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase I...Shannon N Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin
Journal of Clinical Oncology. 2024-01-20 - 1 citationsA rare case of follicular dendritic sarcoma of the vagina.Joann M Gold, Naixin Zhang, Ben Wilson, Amal Masri, Laura Bagwell
Gynecologic Oncology Reports. 2022-08-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
